Leo CEO Bourdon Plots Return To Profit This Year

As Early-Stage R&D Is Axed

 
• By Kevin Grogan
  
Christophe Bourdon
Christophe Bourdon • Source: Leo Pharma
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Dermatological

More from Therapeutic Category